Profile picture

Doctor Kenneth W Mahaffey

Stanford University Medical Center, Stanford (United States of America)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Semaglutide and cardiovascular outcomes by baseline chronic kidney disease status and albuminuria in type 2 diabetes and chronic kidney disease: results from the FLOW trial
Presentation
Semaglutide and cardiovascular outcomes by baseline chronic kidney disease status and albuminuria in type 2 diabetes and chronic kidney disease: results from the FLOW trial
Read more
Recognition of heart failure with micro electro-mechanical sensors using commercially available smartphone, the REFLECS study
Presentation
Recognition of heart failure with micro electro-mechanical sensors using commercially available smartphone, the REFLECS study
Read more
Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial
Presentation
Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial
Read more
Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE
Presentation
Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE
Read more

ESC 365 is supported by

novartis Explore sponsored resources